Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and
midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers for …

Currently, brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are widely
used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical …

The natriuretic peptide family consists of three biologically active peptides: atrial natriuretic
peptide (ANP), brain (or B-type) natriuretic peptide (BNP), and C-type natriuretic peptide …

Heart failure patients are classified by ejection fraction (EF) into distinct groups: heart failure
with preserved ejection fraction (HFpEF) or heart failure with reduced ejection fraction …

Background Heart failure with preserved ejection fraction is associated with substantial
morbidity and mortality, but effective treatments are lacking. We assessed the efficacy and …

The use of a large number of cardiovascular biomarkers, meant to complement the use of
the electrocardiogram, echocardiography cardiac imaging, and clinical symptom …

Objectives: This study sought to determine the prognostic value of B-type natriuretic peptide
(BNP) in patients with heart failure with preserved ejection fraction (HFPEF), in comparison …

Heart failure results not only from cardiac overload or injury but also from a complex
interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on …

For many years, the interleukin-1 receptor family member ST2 was an orphan receptor that
was studied in the context of inflammatory and autoimmune disease. However, in 2005, a …

Background—Cardiac biomarkers are strong predictors of adverse outcomes in several
patient populations. We evaluated the prevalence of elevated troponin I and N-terminal pro …